Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | CTSG | P08311 | 6/20 | 0.44 |
| ▸ | CMA1 | P23946 | 5/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | USP30 | Q70CQ3 | 2/20 | 0.39 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11906254 | 0.92 | GAA (0.47) | CTSLGAARAB9A | |
| SCHEMBL11921829 | 0.90 | CTSL (0.45) | CTSLGAARAB9A | |
| SCHEMBL11926048 | 0.89 | GAA (0.51) | GAARAB9ACTSGCMA1L3MBTL1 | |
| SCHEMBL11921833 | 0.81 | GAA (0.52) | CTSLGAARAB9ACTSGCMA1 | |
| SCHEMBL11907538 | 0.81 | GAA (0.55) | CTSLGAARAB9AL3MBTL1 | |
| SCHEMBL11925979 | 0.78 | GAA (0.60) | GAARAB9ACTSGCMA1L3MBTL1 | |
| SCHEMBL12471343 | 0.77 | PTPN1 (0.61) | MEN1KMT2A | |
| SCHEMBL16843153 | 0.76 | CTSL (0.42) | CTSLGAARAB9AL3MBTL1 | |
| SCHEMBL22036088 | 0.76 | LNPEP (0.55) | GAARAB9AL3MBTL1 | |
| SCHEMBL11921828 | 0.75 | CA2 (0.56) | CTSLGAARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120208896-A1 | AMINO ACID DERIVATIVES AND ABSORABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC. (US) | 2012-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120208896-A1 | AMINO ACID DERIVATIVES AND ABSORABLE POLYMERS THEREFROM | SLC7A1, SLC3A2, BCAT2 | CTSL 1916/4885GAA 2297/4885RAB9A 3509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.